Shares of NanoString Technologies, Inc. (NASDAQ:NSTG – Get Rating) have received a consensus recommendation of “Hold” from the eight brokerages that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $39.14.
NSTG has been the topic of a number of research reports. Cowen cut their price objective on NanoString Technologies to $31.00 in a report on Tuesday, August 9th. Morgan Stanley cut their price objective on NanoString Technologies from $30.00 to $28.00 and set an “equal weight” rating on the stock in a report on Monday, August 8th. Finally, Robert W. Baird cut their price objective on NanoString Technologies from $30.00 to $21.00 in a report on Friday, August 5th.
NanoString Technologies Trading Down 1.2 %
Shares of NASDAQ:NSTG opened at $12.86 on Tuesday. The business’s 50-day moving average is $13.98 and its 200 day moving average is $18.00. NanoString Technologies has a 1 year low of $11.12 and a 1 year high of $51.20. The firm has a market capitalization of $597.91 million, a P/E ratio of -4.23 and a beta of 1.87. The company has a debt-to-equity ratio of 2.00, a current ratio of 6.84 and a quick ratio of 6.04.
NanoString Technologies (NASDAQ:NSTG – Get Rating) last announced its quarterly earnings data on Thursday, August 4th. The biotechnology company reported ($0.85) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.62) by ($0.23). The firm had revenue of $32.22 million during the quarter, compared to analyst estimates of $32.32 million. NanoString Technologies had a negative net margin of 97.45% and a negative return on equity of 87.86%. The firm’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same period in the prior year, the company posted ($0.60) earnings per share. On average, research analysts predict that NanoString Technologies will post -2.55 earnings per share for the current fiscal year.
Institutional Trading of NanoString Technologies
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Guggenheim Capital LLC grew its holdings in NanoString Technologies by 3.5% during the first quarter. Guggenheim Capital LLC now owns 19,410 shares of the biotechnology company’s stock worth $675,000 after acquiring an additional 659 shares during the period. LPL Financial LLC boosted its position in NanoString Technologies by 3.9% during the second quarter. LPL Financial LLC now owns 20,563 shares of the biotechnology company’s stock worth $261,000 after purchasing an additional 779 shares in the last quarter. Advisor Group Holdings Inc. boosted its position in NanoString Technologies by 21.1% during the first quarter. Advisor Group Holdings Inc. now owns 4,595 shares of the biotechnology company’s stock worth $162,000 after purchasing an additional 800 shares in the last quarter. First Republic Investment Management Inc. boosted its position in NanoString Technologies by 4.4% during the second quarter. First Republic Investment Management Inc. now owns 22,393 shares of the biotechnology company’s stock worth $284,000 after purchasing an additional 953 shares in the last quarter. Finally, Green Alpha Advisors LLC boosted its position in NanoString Technologies by 10.1% during the first quarter. Green Alpha Advisors LLC now owns 10,738 shares of the biotechnology company’s stock worth $373,000 after purchasing an additional 986 shares in the last quarter.
NanoString Technologies Company Profile
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.
Receive News & Ratings for NanoString Technologies Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for NanoString Technologies and related companies with MarketBeat.com’s FREE daily email newsletter.